Magnesium aspartate hydrochloride
Magnesium aspartate hydrochloride has been studied in 6 papers since 1985: 6 trials in people. The newest paper, Mar 1, 2011: “Oral magnesium supplementation reduces insulin resistance in non-diabetic subjects - a double-blind, placebo-controlled, randomized trial”.
“NIPTS was significantly more frequent and more severe in the placebo group than in the magnesium group, especially in bilateral damages.”
None of its findings points the other way.
- 6 independent labs in 7 countries
- Human trial6
Studies in people
See all 66 studies gave magnesium aspartate hydrochloride to people and measured what changed.
down: Decreases fasting plasma glucose
up: Improves insulin sensitivity
no change: Has no effect on blood pressure
Randomized trial6 months
In normomagnesemic, overweight, insulin resistant, non-diabetic subjects
Diabetes, obesity & metabolism, Mar 1, 2011
down: Decreases diastolic blood pressure-3.4 mm Hg (95% CI 1.3, 5.6; P = 0.003)
up: Increases urinary magnesium excretion+50%
Randomized trial91 peopleWomenmiddle-aged and elderly6 mo
Midlife adults; Older adults; Patient cohorts
The American journal of clinical nutrition, Jul 1, 1994
down: Decreases noise-induced hearing loss
Randomized trial300 peopleyoung2 months
General population
American journal of otolaryngology, Jan 1, 1994
no change: Has no effect on blood pressure
no change: Has no effect on serum lipids
Randomized trial13 people3 mo
In magnesium-replete patients with mild hypertension
The American journal of clinical nutrition, Apr 1, 1990
no change: Has no effect on blood pressure
up: Increases urinary magnesium4.4 +/- 0.6 to 6.1 +/- 1 mmol/day P less than 0.001
up: Increases urinary calcium4.3 +/- 0.7 to 5.5 +/- 0.9 mmol/day P less than 0.01
Randomized trial8 weeks
Mild hypertensive subjects on a moderately low sodium diet
Clinical and experimental pharmacology & physiology, Apr 1, 1989
What did studies of Magnesium aspartate hydrochloride find?
13Studies of Magnesium aspartate hydrochloride measured 13 outcomes; the most studied are blood pressure (4 studies), urinary magnesium (2) and lipid profile (1).
Blood pressure
no changein humans4
4 studies
Blood pressure
no changein humans4
Magnesium aspartate hydrochloride has no effect on blood pressure in humans.
“Blood pressure and lipid profile did not show significant changes.”
Human trialin normomagnesemic, overweight, insulin resistant, non-diabetic subjects6 months
Diabetes, obesity & metabolism
Magnesium aspartate hydrochloride has no effect on blood pressure in humans.
“magnesium aspartate therapy had no effect on blood pressure, lipid concentrations, or erythrocyte cation metabolism.”
Human trialin magnesium-replete patients with mild hypertension40 mmol Mg aspartate (20 mmol elemental Mg twice daily)3 mon = 13
The American journal of clinical nutrition
Magnesium aspartate hydrochloride has no effect on blood pressure in humans.
“There was no fall in blood pressure with magnesium supplementation and no significant difference in blood pressure between groups at the end of the study.”
Human trialmild hypertensive subjects on a moderately low sodium diet8 weeks
Magnesium supplementation in mild hypertensive patients on a moderately low sodium diet
Clinical and experimental pharmacology & physiology
Magnesium aspartate hydrochloride has no effect on blood pressure in humans.
“there was no fall in blood pressure compared with either treatment with placebo or values before treatment”
Human trialessential hypertension15 mmol magnesium/dayone monthn = 17
Lack of effect of oral magnesium on high blood pressure: a double blind study
British medical journal (Clinical research ed.)
Urinary magnesium
upin humans2
2 studies
Urinary magnesium
upin humans2
Magnesium aspartate hydrochloride increases urinary magnesium in humans (4.4 +/- 0.6 to 6.1 +/- 1 mmol/day P less than 0.001).
“In the magnesium group there was an increase in urinary magnesium (4.4 +/- 0.6 to 6.1 +/- 1 mmol/day P less than 0.001)”
Human trialmild hypertensive subjects on a moderately low sodium dieturine10 mmol/day8 weeks
Magnesium supplementation in mild hypertensive patients on a moderately low sodium diet
Clinical and experimental pharmacology & physiology
Magnesium aspartate hydrochloride increases urinary magnesium in humans.
“significant increase in urinary excretion of magnesium while taking magnesium aspartate”
Human trialessential hypertension15 mmol magnesium/dayone monthn = 17
Lack of effect of oral magnesium on high blood pressure: a double blind study
British medical journal (Clinical research ed.)
Lipid profile
no changein humans1
1 study
Lipid profile
no changein humans1
Magnesium aspartate hydrochloride has no effect on lipid profile in humans.
“Blood pressure and lipid profile did not show significant changes.”
Human trialin normomagnesemic, overweight, insulin resistant, non-diabetic subjects6 months
Diabetes, obesity & metabolism
Insulin sensitivity
upin humans1
1 study
Insulin sensitivity
upin humans1
Magnesium aspartate hydrochloride improves insulin sensitivity in humans.
“oral Mg supplementation improves insulin sensitivity even in normomagnesemic, overweight, non-diabetic subjects”
Human trialin normomagnesemic, overweight, insulin resistant, non-diabetic subjects6 months
Diabetes, obesity & metabolism
Fasting plasma glucose
downin humans1
1 study
Fasting plasma glucose
downin humans1
Magnesium aspartate hydrochloride decreases fasting plasma glucose in humans.
“Mg supplementation resulted in a significant improvement of fasting plasma glucose and some insulin sensitivity indices (ISIs) compared to placebo.”
Human trialin normomagnesemic, overweight, insulin resistant, non-diabetic subjects6 months
Diabetes, obesity & metabolism
Urinary magnesium excretion
upin humans1+50%
1 study
Urinary magnesium excretion
upin humans1+50%
Magnesium aspartate hydrochloride increases urinary magnesium excretion in humans (+50%).
“Urinary magnesium excretion in the magnesium group increased by 50% during the intervention period.”
Human trial20 mmol Mg/d6 mofemalesn = 91
The American journal of clinical nutrition
Diastolic blood pressure
downin humans1
1 study
Diastolic blood pressure
downin humans1
Magnesium aspartate hydrochloride decreases diastolic blood pressure in humans (-3.4 mm Hg (95% CI 1.3, 5.6; P = 0.003)).
“diastolic blood pressure by 3.4 mm Hg (1.3, 5.6; P = 0.003) more in the magnesium group than in the placebo group”
Human trial20 mmol Mg/d6 mofemalesn = 91
The American journal of clinical nutrition
Noise-induced hearing loss
downin humans1
1 study
Noise-induced hearing loss
downin humans1
Magnesium aspartate hydrochloride decreases noise-induced hearing loss in humans.
“NIPTS was significantly more frequent and more severe in the placebo group than in the magnesium group, especially in bilateral damages.”
Human trial6.7 mmol (167 mg)2 months
Oral magnesium intake reduces permanent hearing loss induced by noise exposure
American journal of otolaryngology
cellular cation metabolism
no changein humans1
1 study
cellular cation metabolism
no changein humans1
Magnesium aspartate hydrochloride has no effect on cellular cation metabolism in humans.
“magnesium aspartate therapy had no effect on blood pressure, lipid concentrations, or erythrocyte cation metabolism.”
Human trialin magnesium-replete patients with mild hypertension40 mmol Mg aspartate (20 mmol elemental Mg twice daily)3 mon = 13
The American journal of clinical nutrition
Serum lipids
no changein humans1
1 study
Serum lipids
no changein humans1
Magnesium aspartate hydrochloride has no effect on serum lipids in humans.
“magnesium aspartate therapy had no effect on blood pressure, lipid concentrations, or erythrocyte cation metabolism.”
Human trialin magnesium-replete patients with mild hypertension40 mmol Mg aspartate (20 mmol elemental Mg twice daily)3 mon = 13
The American journal of clinical nutrition